The clinical usefulness of granulocyte transfusions for treatment or preven
tion of life-threatening bacterial and fungal infections remains controvers
ial. Clinical benefit has long been limited by insufficient donor stimulati
on regimens and suboptimal leukapheresis techniques, Methodologic progress,
in particular mobilization of neutrophils in healthy donors by administrat
ion of G-CSF, has significantly enhanced leukapheresis yields. A newly publ
ished study indicates that unrelated community donors can be effectively an
d safely used as an alternative to related family donors. Furthermore, seve
ral recent studies suggest that it may be possible to store granulocyte con
centrates for 24 to 48 hours with adequate preservation of neutrophil funct
ion, This review summarizes the current role of granulocyte transfusion the
rapy in infectious diseases and highlights important recent advances. (C) 2
001 Lippincott Williams & Wilkins, Inc.